Menu
Back to Journals » International Journal of Nephrology and Renovascular Disease » Volume 14
Validity of Urinary Monoamine Assay Sales Under the “Spot Baseline Urinary Neurotransmitter Testing Marketing Model” [Retraction]
Hinz M, Stein A, Uncini T. Int J Nephrol Renovasc Dis. 2011;4:101–113.
The Editor-in-chief and Publisher of International Journal of Nephrology and Renovascular Disease wish to retract the published article.
This review article cites several original research articles published by the authors, which have recently been retracted. This article draws on the findings from those original research articles to form central arguments and discussion, and as a result of the research articles’ retraction, the argument presented in this article is no longer valid and the editor has determined it should be retracted.
Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.
© 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.